Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05229016 · ClinicalTrials.gov registry record · NA

Priming and Patient Reported Outcome Measures

A NA study of Patient Participation and PROM, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
900
Enrollment target
1
Study location

NCT05229016: Completed NA study of Patient Participation and PROM, sponsored by Columbia University.

NCT05229016 is a NA study of Patient Participation and PROM that has completed, run by Columbia University. The registered enrollment target is 900 participants, below the 188,378-participant average among 5 other Patient Participation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05229016, a NA study of Patient Participation and PROM, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
900 participants
Enrollment target
1
Study location

Study Summary

The objective of the study is to assess which health-related questionnaire is the most accurate and reliable. The hypothesis is that some health-related questionnaires are more reliable than others.

Primary Outcome

For the EQ-5D-5L, a scale of 1 to 5 with descriptors is used to score the domains of mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression. A higher score represents a worse outcome.

Interventions

  • BEHAVIORAL Reflection on health-related experiences

Study Locations (1)

New York

  • New York Presbyterian Hospital- Columbia University - New York

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2021-11-09
Est. Completion 2022-02-28
Phase NA
Columbia University

958 total trials

What the finished NCT05229016 record still lists

NCT05229016 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 188,378-participant average among 5 other Patient Participation trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Patient Participation appearing as the primary indexed condition, and to 1 intervention - of which Reflection on health-related experiences is the first listed.

NCT05229016 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05229016 about?

NCT05229016 is a clinical study titled "Priming and Patient Reported Outcome Measures". The objective of the study is to assess which health-related questionnaire is the most accurate and reliable. The hypothesis is that some health-related questionnaires are more reliable than others.

What is the current status of trial NCT05229016?

This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2021-11-09. Estimated completion is 2022-02-28.

What conditions does trial NCT05229016 study?

This clinical trial studies the following conditions: Patient Participation, PROM.

What interventions are being tested in trial NCT05229016?

The interventions under investigation include: Reflection on health-related experiences (BEHAVIORAL).

Who is sponsoring clinical trial NCT05229016?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05229016 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Participation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05229016, the US trial registry maintained by the National Library of Medicine. NCT05229016 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.